Direxion Daily Healthcare Bull 3x Shares (CURE)

NYSEARCA: CURE · IEX Real-Time Price · USD
103.39
-4.59 (-4.25%)
Apr 12, 2024, 4:00 PM EDT - Market closed
-4.25%
Assets $184.06M
Expense Ratio 0.96%
PE Ratio 24.11
Shares Out 1.70M
Dividend (ttm) $1.92
Dividend Yield 1.86%
Ex-Dividend Date Mar 19, 2024
Payout Ratio 44.76%
1-Year Return -2.31%
Volume 35,778
Open 106.64
Previous Close 107.98
Day's Range 102.48 - 106.64
52-Week Low 75.39
52-Week High 127.50
Beta 1.66
Holdings 70
Inception Date Jun 15, 2011

About CURE

Fund Home Page

The Direxion Daily Healthcare Bull 3x Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is issued by Direxion.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol CURE
ETF Provider Direxion
Index Tracked Health Care Select Sector

Top 10 Holdings

270.94% of assets
Name Symbol Weight
HEALTH CARE SELECT SECTOR INDEX SWAP n/a 121.11%
HEALTH CARE SELECT SECTOR INDEX SWAP n/a 53.07%
HEALTH CARE SELECT SECTOR INDEX SWAP n/a 45.40%
GOLDMAN FINL SQ TRSRY INST 506 n/a 11.69%
Eli Lilly and Company LLY 9.33%
DREYFUS GOVT CASH MAN INS n/a 9.05%
UnitedHealth Group Incorporated UNH 6.29%
Johnson & Johnson JNJ 5.52%
Merck & Co., Inc. MRK 4.92%
AbbVie Inc. ABBV 4.56%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Mar 19, 2024 $0.35548 Mar 26, 2024
Dec 21, 2023 $0.57266 Dec 29, 2023
Sep 19, 2023 $0.45383 Sep 26, 2023
Jun 21, 2023 $0.53725 Jun 28, 2023
Mar 21, 2023 $0.48743 Mar 28, 2023
Dec 20, 2022 $0.14407 Dec 28, 2022
Full Dividend History

News

Healthcare Showing That Big Tech Isn't the Only Bull in Town

While capital markets are seemingly fixated on the astounding returns of big tech and the growth prospects of artificial intelligence (AI), the sector isn't the only bull in town. The healthcare secto...

6 weeks ago - ETF Trends

Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch

The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations. CURE is a triple leve...

2 years ago - Benzinga

Direxion Leveraged Healthcare ETF Ready To Make House Calls In 2021

Coronavirus vaccines are being distributed, but case counts continue rising, a pair of scenarios ensuring the healthcare center will again be an epicenter of activity in 2021. What Happened Healthcare...

3 years ago - Benzinga

Healthcare Sector Is Gonna Get Exciting, Capture That With CURE

The healthcare sector is shaking off rust accrued earlier this year and with the 2020 election season mostly behind the group – pending next month's Georgia Senate runoff elections – market observers ...

3 years ago - Benzinga

A CURE For The Common Earnings Play

It has the potential to be lost in this week's earnings hubbub, which is dominated by growth-ier communication services and technology stocks, but don't sleep on reports from blue-chip healthcare stoc...

4 years ago - Benzinga

3 Leveraged Healthcare ETFs Soaring This Month

The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...

Other symbols: LABUPILL
4 years ago - Benzinga

Jablonski: Biotech presents a good buying opportunity

Sylvia Jablonski of Direxion discusses why biotech stocks and ETFs are attractive right now, due to their cheapness relative to the rest of the market.

Other symbols: LABUXLV
4 years ago - CNBC Television

It's Time To Consider Leveraged Healthcare ETFs

For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven t...

Other symbols: LABU
5 years ago - Benzinga